Microsoft nominates GSK CEO Walmsley to board
FILE PHOTO: GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain, October 9, 2017. Picture taken October 9, 2017. REUTERS/Toby Melville
(Reuters) - Microsoft Corp said on Thursday it has nominated GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley to its board of directors.
The software company said former chairman of the board of management at BMW AG, Helmut Panke, will not seek a re-election to the board after his current term expires.
Charles Noski, former vice chairman of AT&T Inc and Bank of America Corp, is also leaving the board.
The company's annual shareholder meeting is due on Dec.4.
Shares of the company were up 1.84% in after-market trading after rising to a record high during the regular trading hours after it announced a $40 billion share buyback plan.
(Reporting by Neha Malara in Bengaluru; Editing by Arun Koyyur)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi upgrades Knight-Swift and Saia to Buy after trucking stock pullback
- Bank of America raises natural gas forecast on supply concerns
Create E-mail Alert Related Categories
General News, ReutersRelated Entities
Stock Buyback, BMW AG, BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share